NEW YORK TIMES: SMS Assist, a No-Glamour Start-Up, Becomes a Unicorn
Chicago’s latest unicorn is all about grit. Unicorns – or private, venture capital-backed companies that are valued above $1 billion –...
ASSOCIATED PRESS: Exelon to close 2 nuclear plants; still seeking subsidies
Exelon Corp. said Thursday that it will shut two Illinois nuclear power plants after the Legislature failed to approve a...
CHICAGO TRIBUNE: Exelon makes another try for energy changes that critics call bailout
Exelon is trying to orchestrate an unlikely end-of-session deal to pass far-reaching legislation to prop up what it says are financially...
NORTH AMERICAN WINDPOWER: Acciona reaches 1 GW milestone with concrete tower tech
By the final quarter of 2015, Acciona Windpower reached a major milestone in the US, with its concrete towers installed in several states...
CRAIN'S CHICAGO: The Pritzkers just bought a piece of your coffee cup
Following a new company acquisition, Lynne Marek of Crain's Chicago Business writes about Pritzker Group Private Capital and those little...
CHICAGO TRIBUNE: Jeff Aronin of Marathon Pharmaceuticals on life after a $900M exit
After selling his pharmaceutical company, Ovation Pharmaceuticals, in 2009, Marathon Pharmaceuticals CEO Jeff Aronin sat down with the...
BLOOMBERG: Acciona to build 805.5 megawatts of wind power in North America
Acciona announced its windpower division's plans for growth in North America with a press conference during the industry's annual trade...
CHICAGO SUN-TIMES: Exelon’s rate-hike proposal is a bad bill
Following a rate hike proposal from Exelon, Aileron teamed with the BEST Coalition to increase awareness of the issue and empower...
ASSOCIATED PRESS: Exelon subsidy would cost $1.6B over 5 years
Aileron worked with the BEST Coalition and independent experts to develop an economic impact study of proposed Illinois energy...
CHICAGO TRIBUNE: Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016
The Chicago Tribune spoke to families and advocates seeking better treatment options for Duchenne muscular dystrophy as part of their...
